VKORC1 Haplotypes in patients treated with warfarin
Background: Warfarin has very narrow therapeutic windows and large individual variability. Genetic variants encoding VKORC1 gene has resulted in altered sensitivity to warfarin or warfarin resistance. Nine haplotypes (H1-H9) of VKORC1 had been categorized with reference to 10 SNPs (Gen Bank accessio...
Main Authors: | Beshna, E, Teh , Lay Kek, Ngow, Harris Abdullah, Harun, Roslan, Salleh, Mohd Zaki |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/5241/ http://irep.iium.edu.my/5241/1/Pharmacogenomic_VKROC1_Halotype_Abstract_Poster.pdf |
Similar Items
-
Lack of correlation between INR and warfarin dose: a role of pharmacogenotyping of CYP2C9*3 and VKORC1 for anticoagulation
by: Salleh, Mohd Zaki, et al.
Published: (2009) -
CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia
by: Ngow, Harris Abdullah, et al.
Published: (2009) -
Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin
by: Teh, L. K., et al.
Published: (2011) -
Role of pharmacodiagnostic of CYP2C9 variants in the optimization of warfarin therapy in Malaysia: a 6-month follow-up study
by: Ngow, Harris Abdullah, et al.
Published: (2008) -
Genetic Polymorphism of CYP2D6 and MDR1 in breast cancer patients treated with tamoxifen
by: Mohamad, NI, et al.
Published: (2010)